bioMérieux SA

bioMérieux SA is a global leader in in vitro diagnostics (IVD), specializing in infectious disease testing, microbiology, molecular diagnostics, immunoassays, and industrial microbiological quality control solutions. Founded in 1963 and headquartered in Marcy-l’Étoile, near Lyon, France, the company operates in more than 45 countries and distributes its diagnostic solutions to over 160 countries worldwide.

The company develops innovative diagnostic systems that help hospitals, clinical laboratories, physicians, pharmaceutical manufacturers, and food safety organizations rapidly detect infectious diseases and antimicrobial resistance. bioMérieux’s portfolio includes automated blood culture systems, molecular diagnostic platforms, syndromic testing, immunoassays, microbiology analyzers, laboratory automation solutions, and digital laboratory software.

bioMérieux is internationally recognized for pioneering technologies that support antimicrobial stewardship, infection prevention, public health surveillance, and precision diagnostics. The company continuously invests in molecular biology, artificial intelligence, automation, and data-driven laboratory solutions to improve diagnostic accuracy and laboratory efficiency.

Its research centers and manufacturing facilities operate under strict international quality standards while complying with US FDA, European IVDR, ISO 13485, and other global regulatory requirements. Through scientific innovation and close collaboration with healthcare professionals, bioMérieux continues to advance clinical diagnostics and improve patient outcomes worldwide.